Sun Pharma Adv. Res Share Price

Sun Pharma Adv. Res (INR)218.25-1.5   (-0.7%)

Exchange ScripsBSE532872NSESPARCISININE232I01014

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Sun Pharma Adv. Res Performance

Market performance
Open price221.4
High221.9
Volumes629876
Prev Close218.25
Low215.26
Closing date2024-09-19
Historical performance
1 Year High472.80
3 Year High472.80
5 Year High472.80
1 Year Low196.10
3 Year Low162.10
5 Year Low81.00

Sun Pharma Adv. Res Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
11957
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
-18.25
Dividend Yield
Dividend Yield
N/A

Sun Pharma Adv. Res Investment Returns

1 Year
-7%
3 Years
-24.9%
5 Years
42.5%
10 Years
10.9%

Sun Pharma Adv. Res Technicals

IndicatorsValueSignal
5-DMA222.57Bearish
10-DMA225Bearish
20-DMA225.66Bearish
50-DMA224.34Bearish
100-DMA225.1Bearish
200-DMA287.09Bearish

Shareholding Pattern

FieldJun-2024Mar-2024Dec-2023Sep-2023Jun-2023
Promoters1414141414
Foreign Investors---------------
Domestic Investors1414141414
Public Investors125170102729103976101419100793
Government11111

Sun Pharma Adv. Res Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023
Sales------
Operating Expenses14021803
Other Income295109
Operating Profit-3726-2032
Interest1776
Depreciation125118
Profit Before Tax-3868-2226
Consolidated Net Profit-3872-2226
Adjusted EPS-12-7

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023
Share Capital325325
Total Reserves9334803
Minority Interest------
Total Non-Current Liabilities12301384
Total Liabilities51388301
Capital Work in Progress1319
Total Assets51388301

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023
Cash Flow from Operating Activities-4292-691
Cash Flow from Investing Activities3915-5483
Cash Flow from Financing Activitie4246168
Net Cash Inflow / Outflow47-6
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of -18.25.
  • 3Y Stock Price CAGR of the stock is -8.5.
  • The stock has a beta of 1.0.
  • In the last financial year, the company had an EBITDA of ₹-3743 Million.
  • The company generated revenue of ₹755 Million in the previous financial year.

Sun Pharma Adv. Res

218.25-1.5   (-0.7%)

Investment Amount: ₹ 23135
Current Value: ₹ 21825
Performence: -5.7%
P/L: ₹ -1310
Top Gainers
SymbolChange%
HITECHCORP264.62(20%)
NEOGEN2183.15(16%)
ROSSELLIND621.65(12%)
AGIIL1108.15(12%)
PEARLPOLY45.18(10%)
Top Losers
SymbolChange%
IDEA10.38(-20%)
DANGEE7.67(-11%)
ECOSMOBLTY500.75(-10%)
SILGO45.39(-10%)
PTC214.65(-9%)
INDUSTOWER389.8(-9%)
RPPL40.85(-9%)
EIFFL195.05(-9%)
Similar stocks

Future MarketNetwork

58.5

11.43

August 19 - September 19

Medi Assist Health

19

669.05

August 19 - September 19

AGS Transact Tech

16.5

105.79

August 19 - September 19

Syngene Internation.

9.4

902.1

August 19 - September 19

Krystal Integrated

6

766.6

August 19 - September 19

RK Swamy

1.6

258.85

August 19 - September 19

PTL Enterprises

-2.7

43.44

August 19 - September 19

Latent View Analytic

-3.3

478.45

August 19 - September 19

Announcing Stock of the Month!

 

Phone

Registered Users

10 lacs

Google Rating

4.6